Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care.
COMING SOON:
Webinar #17: A New Year of COVID — The State of the Pandemic & U.S. Strategy in 2021
The latest COVID-19 Conversations webinar covered the next steps for ensuring COVID-19 vaccines reach the public, including overcoming vaccine hesitancy, ensuring a robust supply chain and communicating clearly and consistently throughout.
Our expert panel:
- Jewel Mullen (Moderator), Associate Dean for Health Equity, University of Texas at Austin Dell Medical School
- Paul Offit, Director, Vaccine Education Center, Children's Hospital of Philadelphia
- Julie Swann, Department Head, Edward P. Fitts Department of Industrial and Systems Engineering, NC State University
- Noel Brewer, Professor, Department of Health Behavior, University of North Carolina Gillings School of Global Public Health
- Katie Greene, Visiting Policy Associate, Duke-Margolis Center for Health Policy
MORE ABOUT THE WEBINAR SERIES
The webinar series draws from and complements existing advisory activities underway at APHA and the National Academies, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19.
The series rapidly and regularly provides trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers, public health and health care officials, and the general public.
The series is exploring the scientific basis for guidance issued by government, health and public health organizations, and industry, as well as answering questions that are top of mind for its audiences.
Questions? Contact us.